Xenagos Bio
Xenagos Bio is a startup headquartered in Philadelphia, United States, founded in 2025. It has raised at least $2.5m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the seed stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Xenagos Bio has raised at least $2.5m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Xenagos Bio sits inside the Philadelphia region R&D ecosystem in the Global R&D Labs Directory.
Other startups in Philadelphia
- Alveus Therapeutics
- BlueWhale Bio
- Daymark Health
- FORE US Bio
- Interius BioTherapeutics
- Metabolics Pharma
- OnCall Health
- Peptaris
- QualiaOS
- Ritten
- Tolerance Bio
Related
- Innovation profile of Philadelphia
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Xenagos Bio do?
Xenagos Bio is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has Xenagos Bio raised?
At least $2.5m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Xenagos Bio based?
Xenagos Bio is headquartered in Philadelphia, United States.
When was Xenagos Bio founded?
Xenagos Bio was founded in 2025.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.